Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{160181,
        author = {Nikita Mishra and Dr. Amit Tiwari},
        title = {Study and categorization of MDR production potential of isolated microbial species isolated from different areas of Rewa district},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {9},
        number = {12},
        pages = {1243-1248},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=160181},
        abstract = {During the past decades, the microbial world have provided many important bioactive compounds of high commercial value. Over 5000 antibiotics have been identified from the cultures of Gram-positive, Gram-negative and filamentous fungi, but only about 100 antibiotics alone have been used commercially to treat human, animal, and plant diseases. These searches have been remarkably successful, and approximately two-thirds of naturally occurring antibiotics have been isolated from microbes. The need for less toxic, more potent antibiotics from noninfective organisms. Microbes, which are prolific producers of antibiotics and important suppliers to the pharmaceutical industry, can produce a wide variety of secondary metabolites. Consequently, they are continuing to be routinely screened for new bioactive substances.},
        keywords = {pharmaceutical industry, non-infective, Gram-positive, antibiotics.},
        month = {},
        }